
Lite Strategy
Clinical-stage pharmaceutical company(NASDAQ: LITS)
Lite Strategy
@Lite Strategyfan202
Siguiendo1
Índice de influencia57
Proyectos similares
*Si no se puede hacer clic, significa que no hay información detallada disponible.

OSL Group
Investment holding company(0863.HK)
Mega Matrix Inc.
US-listed companies focusing on blockchain finance and digital content(NYSE American: MPU)
Bitcoin Group SE
Acquisition Portfolio Companies (ADE.DE)
Ming Shing Group
Wet trades works services company(NAQ: MSW)
Anap Holdings Inc.
Japanese apparel retailer(3189.T)
SenseTime Group Limited
AI Technology Company (HKEX: 0020.HK)
Convano Inc
Nail art operation listed company (TSE: 6574.T)
The Smarter Web Company
Web Design Digital Marketing Services(AQUIS: SWC)Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Detalles de la recaudación de fondos
Ronda de financiación | Cantidad | Valuación | Date | Inversores |
---|---|---|---|---|
Post-IPO | €85.39M | -- | 2025-07-21 | -- |